Skip to main content
Caplight Logo









Mamotest

Mamotest

Private
Buenos AiresHealthcare & Life Scienceshttps://mamotest.com/

Last Round

Early Funding

Mar 27, 2023

Total Funding Raised

$4.9M

Company Overview

Mamotest is a healthtech company that provides an AI-powered telemammography network and patient navigation platform to improve access to early breast cancer diagnosis and treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Telemedicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Revenue Share

AI Layer

Application

Keywords

teleradiologymedical imagingAI-assisted triagebreast cancer screeningtelemedicinediagnostic imagingradiology AIpatient navigationanomaly detectiondigital healthcloud diagnostic platformhealthtechAI diagnosticsremote diagnosticsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mamotest Comparables

Compare Mamotest with similar companies based on industry and business-model similarity.

Mamotest comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Therapixel
76%
CureMetrix
76%
Qure.ai
70%

Mamotest Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 27, 2023
SeedJun 6, 2021

Key People

Founding team and executive leadership

Nicolas Loperfido

CFO

Executive Team

Mamotest Investors

Notable investors and investment history

Mamotest investors
InvestorRounds
Sonen CapitalEarly Funding
Sky High VCEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Monthly visitors increased 185% MoM, reaching 539.

Mamotest Filings

Explore SEC and related filing metadata, where available.

Mamotest filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mamotest's valuation, stock price, and market status.

Is Mamotest a public or private company?

Mamotest is a private company.

What is the current stock price of Mamotest?

Mamotest is a private company with no public stock price. No recent secondary market data is available.

How much is Mamotest worth (valuation)?

Valuation information for Mamotest is not publicly available.

Can I buy Mamotest stock?

Mamotest shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mamotest's last funding round?

Mamotest's most recent funding round was Early Funding on March 27, 2023.

Who are the main investors in Mamotest?

Key investors in Mamotest include Sonen Capital, Sky High VC.

Will Mamotest IPO soon?

No public IPO plans have been announced for Mamotest.

How can I track Mamotest secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mamotest's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBuenos Aires
Employee Range20
Year Founded2013
Last FundingMar 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?